Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EarliTec Diagnostics
AddedFeb 15, 2024
UpdatedJun 18, 2026
EarliTec Diagnostics

EarliTec Diagnostics

Series A

EarliTec Diagnostics: Pioneering digital health solutions for early ASD detection and treatment.

HQ
Decatur, GA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

EarliTec Diagnostics, founded by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine, and Yale University, is a digital health company dedicated to the early identification and treatment of Autism Spectrum Disorder (ASD) and related disabilities. Their core mission is to make early diagnosis and intervention accessible to children globally. EarliTec's flagship product, EarliPoint, is an FDA-authorized tool that monitors and analyzes children's looking behavior through video scenes of social interactions, providing clinicians with robust data for confident and objective diagnoses.

Notable affiliated individuals include researchers from prestigious institutions like Emory University and Yale University. EarliTec has garnered significant attention for its innovative approach, receiving FDA authorization for EarliPoint, which underscores its clinical reliability. The company has made a substantial impact by empowering healthcare providers with precise diagnostic tools, thereby improving early intervention outcomes for children with ASD.

EarliTec Diagnostics - Similar Companies

Otologic Technologies logo

Otologic Technologies

otologictech.com

Ocular Diagnostics logo

Ocular Diagnostics

Cognoa logo

Cognoa

cognoa.com

SynapDx logo

SynapDx

Test Diagnostics logo

Test Diagnostics

Digital Diagnostics logo

Digital Diagnostics

Accessible Diagnostics logo

Accessible Diagnostics

Early is Good logo

Early is Good

earlyisgood.com

Bold Diagnostics logo

Bold Diagnostics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Biorosa Technologies logo

Biorosa Technologies

biorosa.com

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

Eclipse Diagnostics logo

Eclipse Diagnostics

Emerge Diagnostics logo

Emerge Diagnostics

emergedx.com

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

EarliTec Diagnostics - Quick Facts

Who are EarliTec Diagnostics' competitors?

Companies similar to EarliTec Diagnostics include Otologic Technologies, Ocular Diagnostics, Cognoa and SynapDx.

When was EarliTec Diagnostics founded?

EarliTec Diagnostics was founded in 2019.

Where is EarliTec Diagnostics' headquarters located?

EarliTec Diagnostics' headquarters is located in Decatur, GA, US.

When was EarliTec Diagnostics' last funding round?

EarliTec Diagnostics' most recent funding round was for $19.5M (USD) in February 2022.

How much has EarliTec Diagnostics raised to-date?

As of Feb 18, 2022, EarliTec Diagnostics has raised a total of $19.5M (USD).

How many employees does EarliTec Diagnostics have?

EarliTec Diagnostics has 26 employees as of Feb 5, 2024.

EarliTec Diagnostics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Subscription
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Healthcare
Tags
  • Healthtech
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified